Sequestration takes its toll on FDA user fees paid by industry

The automatic budget cuts known as the federal sequester have taken approximately $85 million in medical device and pharmaceutical FDA user fees away from the agency, the White House's Office of Management & Budget has confirmed. MassDevice reported the news, noting that the cuts are expected to continue. The device and drug industries pay user fees to help fund FDA operations, but the sequester has taken away part of the money and left it in an inaccessible account. In other words, the money is essentially in limbo. Some in Congress are calling for legislation that exempts the FDA user fees from sequestration. Story

Suggested Articles

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.

Ortho Clinical Diagnostics has launched a new chemistry system to complete its integrated Vitros XT line of laboratory solutions.

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.